These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7096542)

  • 1. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
    Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
    J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcitonin concentration in the cerebrospinal fluid in patients with medullary thyroid carcinoma--passing of calcitonin through the blood-brain barrier].
    Morimoto S; Onishi T; Nishimura J; Fukuo K; Lee S; Kono H; Imanaka S; Okada Y; Kumahara Y
    Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1125-8. PubMed ID: 7175316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive calcitonin in human cerebrospinal fluid.
    Pavlinac DM; Lenhard LW; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1980 Apr; 50(4):717-20. PubMed ID: 7364928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
    Saito H; Saito S
    Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
    Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
    Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
    Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
    Carter WB; Taylor RL; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
    Takami H; Ito K
    Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.
    Lee S; Morimoto S; Onishi T; Tsuji M; Okada Y; Seino Y; Ishida M; Yamaoka K; Takai S; Miyauchi A; Kumahara Y
    J Clin Endocrinol Metab; 1982 Aug; 55(2):361-3. PubMed ID: 6979551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine measurement of plasma calcitonin in nodular thyroid diseases.
    Vierhapper H; Raber W; Bieglmayer C; Kaserer K; Weinhäusl A; Niederle B
    J Clin Endocrinol Metab; 1997 May; 82(5):1589-93. PubMed ID: 9141554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
    Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
    J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.